// App-Quantinova.ai

: First UK experience of apalutamide in metastatic and non-metastatic prostate cancer outside of clinical trials.

Researchers

Presenter

  • Prantik Das

Principal Investigators

  • Rania Mohammed

  • Naveed Sarwar

  • Omar Din

  • Ankit Jain

  • Jessica Davies

  • Thangrarajh Mugunthan

  • Ajith Nair

  • Aruni Ghose

  • Seheli Bandyopadhyay

  • Roopesh Krishnappa

  • Pooja Iyer

  • Lauren Jones

  • Nikhil Vasdev

  • Maja Moldawa

  • Rebecca Devine

  • Robert Hughes

  • Anand Sharma

Medical Centers

  • University Hospitals of Derby and Burton NHS Foindayion Trust, Derby, United Kingdom

  • Imperial College, London, United Kingdom

  • Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, United Kingdom

  • The Royal Wolverhampton NHS Trust,Wolverhampton, UK

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

  • Mount Vernon Cancer Centre, Northwood, United Kingdom

  • East & North Herts NHS Trust, Stevenage, United Kingdom

  • Mount Vernon Cancer Centre, Northwood, United Kingdom

  • NHS, Northwood, United Kingdom

  • Weston Park Cancer Centre, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved